Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
Completed · Phase 2
Conditions studied: Lung Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have recurrent or refractory small cell lung cancer.
Key facts
- Study ID
- NCT00005972
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 73
- Starts
- 2000-05-01
- Expected to finish
- 2008-02-01
- Last updated by the study team
- 2016-07-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Veterans Affairs Medical Center - Birmingham — Birmingham, Alabama, United States
- University of California San Diego Cancer Center — La Jolla, California, United States
- Veterans Affairs Medical Center - San Francisco — San Francisco, California, United States
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- CCOP - Christiana Care Health Services — Wilmington, Delaware, United States
- Lombardi Cancer Center — Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- CCOP - Mount Sinai Medical Center — Miami Beach, Florida, United States
- University of Illinois at Chicago Health Sciences Center — Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago (Westside Hospital) — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Hematology Oncology Associates of the Quad Cities — Bettendorf, Iowa, United States
- Holden Comprehensive Cancer Center at The University of Iowa — Iowa City, Iowa, United States
- Veterans Affairs Medical Center - Togus — Togus, Maine, United States
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
- Veterans Affairs Medical Center - Minneapolis — Minneapolis, Minnesota, United States
- University of Minnesota Cancer Center — Minneapolis, Minnesota, United States
- Veterans Affairs Medical Center - Columbia (Truman Memorial) — Columbia, Missouri, United States
- Ellis Fischel Cancer Center - Columbia — Columbia, Missouri, United States
- Barnes-Jewish Hospital — St Louis, Missouri, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- CCOP - Southern Nevada Cancer Research Foundation — Las Vegas, Nevada, United States
- Norris Cotton Cancer Center — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.